Nuclear medicine imaging uses small amounts of radioactive tracers and imaging technologies like gamma cameras and PET/SPECT scanners to visualize how the body functions at the cellular level. It can help detect diseases earlier than other methods and guide treatment. Nuclear medicine is commonly used to diagnose and manage cancers, heart conditions, brain disorders and more. It involves minimal radiation exposure and has been safely used for decades. Future developments may include more hybrid imaging combining modalities to provide both anatomical and functional information.
Quality Assurance Programme in Computed TomographyRamzee Small
Introduction to Computed Tomography
Basic description of the components of a CT System
Introduction to Quality Assurance
Quality Assurance and Quality Control Tests in Computed Tomography base on frequency
Objective of QA/QC Test
https://www.snmclub.com/presentation
PET/MRI Current & Future Status
DALE BAILEY PhD , Principal Physicist
Departement of Nuclear Medicine, Royal North Shore Hospital
Professor in Medical Radiation Sciences, University of Sydney
Sydney, Australia
icrm2018
Here are 7 Applications of Nuclear Medicine Technology: 1. Diagnostic Imaging 2. Myocardial Perfusion Imaging 3. Thyroid Imaging 4. Bone Scans 5. Renal Imaging
Quality Assurance Programme in Computed TomographyRamzee Small
Introduction to Computed Tomography
Basic description of the components of a CT System
Introduction to Quality Assurance
Quality Assurance and Quality Control Tests in Computed Tomography base on frequency
Objective of QA/QC Test
https://www.snmclub.com/presentation
PET/MRI Current & Future Status
DALE BAILEY PhD , Principal Physicist
Departement of Nuclear Medicine, Royal North Shore Hospital
Professor in Medical Radiation Sciences, University of Sydney
Sydney, Australia
icrm2018
Here are 7 Applications of Nuclear Medicine Technology: 1. Diagnostic Imaging 2. Myocardial Perfusion Imaging 3. Thyroid Imaging 4. Bone Scans 5. Renal Imaging
Nuclear Medicine.................
Radioactivity………………
Gamma camera………………
PET scan and SPECT scan…...........
Nuclear Medicine Studies…………..
Nuclear Medicine Team……………
Safety in Nuclear Medicine…………
Here are 10 Types of Diagnostic Imaging: 1. X-Ray Imaging 2. Computed Tomography (CT) Scan 3. Magnetic Resonance Imaging 4. Ultrasound 5. Nuclear Medicine
Nuclear medicine is a medical specialty that uses radiopharmaceuticals to diagnose, treat and monitor diseases. Nuclear medicine and molecular imaging procedures have a long history of use.
Difference between Nuclear Medicines and others imaging modalitiesMINANI Theobald
Nuclear medicines is a branch of medicines deal with the diagnosis and identification of disease. it is better than other medicine because it is more specifics to a given organ , tissues or cells. that is the reason why seems to provoque less harm and is better expressing the reality of disease
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. What is Nuclear Medicine Imaging?
Why are Nuclear Medicine Imaging unique?
How are Nuclear Medicine Imaging used?
How do Nuclear Medicine Imaging work?
Are Nuclear Medicine Imaging safe?
What is the future of Nuclear Imaging?
3. History
What are Nuclear Medicine and Molecular Imaging?
Nuclear medicine is a branch of medical imaging that uses small amounts
of radioactive material to diagnose and determine the severity or treat a
variety of diseases, including many types of cancers, heart disease,
gastrointestinal, endocrine, neurological disorders, and other
abnormalities within the body.
The discovery of x-rays more than a century ago produce primarily
structural pictures only.
In nuclear medicine we are probing deep inside the body to reveal its
inner workings. Nuclear medicine visualizes how the body parts function
and what’s happening at the cellular and molecular levels.
4. With the help of nuclear medicine and molecular imaging,
scientists and healthcare providers are:
Gaining a better understanding of the pathways of disease
Quickly assessing new drugs – to check and to find new
Improving the selection of therapy
Monitoring patient response to treatment
Finding new ways to identify individuals at risk for disease.
5. Why are Nuclear Medicine and Molecular Imaging
unique?
In conventional diagnostic imaging, an external source of
energy such as x-rays, magnetic fields, or ultrasound waves is
used to produce pictures of bone and soft tissue.
In nuclear medicine and molecular imaging procedures, the
energy source is introduced into the body, where it gets
incorporated in a specific tissue, organ, or process and is then
detected by an external device (gamma camera, SPECT or PET
scanners) to provide information on organ function and
cellular activity.
6. The gamma camera is an imaging technique used to carry out
functional scans of the brain, thyroid, lungs, liver, gallbladder, kidneys,
and skeleton.
SPECT (single photon emission computed tomography ) scans -
measure gamma rays, the decay of the radiotracers used.
PET(positron emission tomography) scans - small particles called
positrons.
Since the disease begins with microscopic cell changes, nuclear
medicine has the potential to identify disease in an earlier, more
treatable stage, often before conventional imaging and other tests are
able to reveal abnormalities.
With their ability to identify the early signs of disease and other
abnormalities, nuclear medicine offers the potential to change
medical care from reactive to proactive, saving and improving
countless lives.
7. How is Nuclear Medicine used?
Nuclear medicine is playing an increasingly important role in patient
care, medical research, and pharmaceutical development.
Nuclear medicine is integral to the care of patients with cancer, heart
disease, and brain disorders
Colon, and lung cancer are just a few of the many types of cancer in
which nuclear and molecular imaging can truly change the direction and
and outcome of patient care.
8. A myocardial perfusion scan uses a tiny amount of a radioactive substance,
called a radioactive tracer. The tracer travels through the bloodstream and
is absorbed by the healthy heart muscle. On the scan, the areas where the
tracer has been absorbed look different from the areas that do not absorb
it. Areas that are damaged or don't have good blood flow do not absorb
the tracer.
In addition to helping physicians diagnose dementia(memory loss), nuclear
imaging now offers imaging agents that successfully identify early changes
in the brain associated with Alzheimer’s disease. (Alzheimer's disease is a
progressive disorder that causes brain cells to degenerate and die.
Alzheimer's disease is the most common cause of dementia)
In the laboratory, a better understanding of the molecular pathways and
mechanisms of disease, helps the researchers quickly assess new therapies,
nuclear medicine, and molecular imaging are also contributing to the
accelerated development of new and more effective drugs.
9. How does Nuclear Medicine work?
Nuclear medicine involves a signal-producing imaging agent that is
introduced into the body, usually by injection, and an imaging device
capable of detecting and using the probe’s signals to create detailed
images.
Radiopharmaceutical - the imaging agent is a compound that includes a
small amount of radioactive material called a radiotracer. Radiotracers
(which are also called radiopharmaceuticals or radionuclides) produce a
signal that can be detected by a gamma camera or a positron emission
tomography (PET) scanner.
10. Are Nuclear Medicine and Molecular Imaging safe?
Nuclear medicine diagnostic procedures use small amounts of radioactive
material, sometimes about the same amount of radiation a person receives
in a year of normal living. As a result, the radiation risk involved in such
procedures is very low compared to the potential benefits.
Nuclear medicine specialists use the ALARA principle (As Low As
Reasonably Achievable) to carefully select the amount of radiotracer that
will provide an accurate test with the least amount of radiation exposure to
the patient.
Nuclear medicine procedures have been performed for more than 50 years
on adults and for more than 40 years on infants and children of all ages
without any known adverse effects.
11. What is the future of Nuclear and Molecular Imaging?
Every day, nuclear imaging procedures make a difference in the lives of patients by
contributing to the detection, diagnosis, treatment, and monitoring of disease. With
the development of new technologies and imaging agents, many of which are now in
clinical trials, nuclear medicine and molecular imaging promise to continue to deliver
improvements to patient care.
Hybrid Imaging
The combination of two imaging techniques—called co-registration, fusion imaging,
or hybrid imaging—allows information from two different types of scans to be
viewed in a single set of images. PET/CT and SPECT/CT, a combination of PET or
SPECT and CT, have become standard diagnostic tools because they provide detail on
both the anatomy and the function of organs and tissues.
New forms of hybrid imaging are in use or in development, including PET/MR,
PET/ultrasound, and various optical technologies fused with conventional imaging
techniques.